This report contains market size and forecasts of Pompe Disease Treatment in Global, including the following market information:
Global Pompe Disease Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Pompe Disease Treatment market was valued at 972.6 million in 2020 and is projected to reach US$ 1052.4 million by 2027, at a CAGR of 2.0% during the forecast period.
Publisher has surveyed the Pompe Disease Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pompe Disease Treatment Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Pompe Disease Treatment Market Segment Percentages, By Type, 2020 (%)
Infantile-Onset Pompe Disease
Adult-Onset Pompe Disease
China Pompe Disease Treatment Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Pompe Disease Treatment Market Segment Percentages, By Application, 2020 (%)
Hospital
Medical Center
Other
Global Pompe Disease Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Pompe Disease Treatment Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Pompe Disease Treatment Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Pompe Disease Treatment Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Amicus Therapeutics
Audentes Therapeutics
Sanofi Genzyme
EpiVax
Oxyrane
Sangamo BioSciences
Valerion Therapeutics
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Pompe Disease Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pompe Disease Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pompe Disease Treatment Overall Market Size
2.1 Global Pompe Disease Treatment Market Size: 2021 VS 2027
2.2 Global Pompe Disease Treatment Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pompe Disease Treatment Players in Global Market
3.2 Top Global Pompe Disease Treatment Companies Ranked by Revenue
3.3 Global Pompe Disease Treatment Revenue by Companies
3.4 Top 3 and Top 5 Pompe Disease Treatment Companies in Global Market, by Revenue in 2020
3.5 Global Companies Pompe Disease Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pompe Disease Treatment Players in Global Market
3.6.1 List of Global Tier 1 Pompe Disease Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Pompe Disease Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Pompe Disease Treatment Market Size Markets, 2021 & 2027
4.1.2 Infantile-Onset Pompe Disease
4.1.3 Adult-Onset Pompe Disease
4.2 By Type - Global Pompe Disease Treatment Revenue & Forecasts
4.2.1 By Type - Global Pompe Disease Treatment Revenue, 2016-2021
4.2.2 By Type - Global Pompe Disease Treatment Revenue, 2022-2027
4.2.3 By Type - Global Pompe Disease Treatment Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pompe Disease Treatment Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Medical Center
5.1.4 Other
5.2 By Application - Global Pompe Disease Treatment Revenue & Forecasts
5.2.1 By Application - Global Pompe Disease Treatment Revenue, 2016-2021
5.2.2 By Application - Global Pompe Disease Treatment Revenue, 2022-2027
5.2.3 By Application - Global Pompe Disease Treatment Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Pompe Disease Treatment Market Size, 2021 & 2027
6.2 By Region - Global Pompe Disease Treatment Revenue & Forecasts
6.2.1 By Region - Global Pompe Disease Treatment Revenue, 2016-2021
6.2.2 By Region - Global Pompe Disease Treatment Revenue, 2022-2027
6.2.3 By Region - Global Pompe Disease Treatment Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Pompe Disease Treatment Revenue, 2016-2027
6.3.2 US Pompe Disease Treatment Market Size, 2016-2027
6.3.3 Canada Pompe Disease Treatment Market Size, 2016-2027
6.3.4 Mexico Pompe Disease Treatment Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Pompe Disease Treatment Revenue, 2016-2027
6.4.2 Germany Pompe Disease Treatment Market Size, 2016-2027
6.4.3 France Pompe Disease Treatment Market Size, 2016-2027
6.4.4 U.K. Pompe Disease Treatment Market Size, 2016-2027
6.4.5 Italy Pompe Disease Treatment Market Size, 2016-2027
6.4.6 Russia Pompe Disease Treatment Market Size, 2016-2027
6.4.7 Nordic Countries Pompe Disease Treatment Market Size, 2016-2027
6.4.8 Benelux Pompe Disease Treatment Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Pompe Disease Treatment Revenue, 2016-2027
6.5.2 China Pompe Disease Treatment Market Size, 2016-2027
6.5.3 Japan Pompe Disease Treatment Market Size, 2016-2027
6.5.4 South Korea Pompe Disease Treatment Market Size, 2016-2027
6.5.5 Southeast Asia Pompe Disease Treatment Market Size, 2016-2027
6.5.6 India Pompe Disease Treatment Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Pompe Disease Treatment Revenue, 2016-2027
6.6.2 Brazil Pompe Disease Treatment Market Size, 2016-2027
6.6.3 Argentina Pompe Disease Treatment Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pompe Disease Treatment Revenue, 2016-2027
6.7.2 Turkey Pompe Disease Treatment Market Size, 2016-2027
6.7.3 Israel Pompe Disease Treatment Market Size, 2016-2027
6.7.4 Saudi Arabia Pompe Disease Treatment Market Size, 2016-2027
6.7.5 UAE Pompe Disease Treatment Market Size, 2016-2027
7 Players Profiles
7.1 Amicus Therapeutics
7.1.1 Amicus Therapeutics Corporate Summary
7.1.2 Amicus Therapeutics Business Overview
7.1.3 Amicus Therapeutics Pompe Disease Treatment Major Product Offerings
7.1.4 Amicus Therapeutics Pompe Disease Treatment Revenue in Global (2016-2021)
7.1.5 Amicus Therapeutics Key News
7.2 Audentes Therapeutics
7.2.1 Audentes Therapeutics Corporate Summary
7.2.2 Audentes Therapeutics Business Overview
7.2.3 Audentes Therapeutics Pompe Disease Treatment Major Product Offerings
7.2.4 Audentes Therapeutics Pompe Disease Treatment Revenue in Global (2016-2021)
7.2.5 Audentes Therapeutics Key News
7.3 Sanofi Genzyme
7.3.1 Sanofi Genzyme Corporate Summary
7.3.2 Sanofi Genzyme Business Overview
7.3.3 Sanofi Genzyme Pompe Disease Treatment Major Product Offerings
7.3.4 Sanofi Genzyme Pompe Disease Treatment Revenue in Global (2016-2021)
7.3.5 Sanofi Genzyme Key News
7.4 EpiVax
7.4.1 EpiVax Corporate Summary
7.4.2 EpiVax Business Overview
7.4.3 EpiVax Pompe Disease Treatment Major Product Offerings
7.4.4 EpiVax Pompe Disease Treatment Revenue in Global (2016-2021)
7.4.5 EpiVax Key News
7.5 Oxyrane
7.5.1 Oxyrane Corporate Summary
7.5.2 Oxyrane Business Overview
7.5.3 Oxyrane Pompe Disease Treatment Major Product Offerings
7.5.4 Oxyrane Pompe Disease Treatment Revenue in Global (2016-2021)
7.5.5 Oxyrane Key News
7.6 Sangamo BioSciences
7.6.1 Sangamo BioSciences Corporate Summary
7.6.2 Sangamo BioSciences Business Overview
7.6.3 Sangamo BioSciences Pompe Disease Treatment Major Product Offerings
7.6.4 Sangamo BioSciences Pompe Disease Treatment Revenue in Global (2016-2021)
7.6.5 Sangamo BioSciences Key News
7.7 Valerion Therapeutics
7.7.1 Valerion Therapeutics Corporate Summary
7.7.2 Valerion Therapeutics Business Overview
7.7.3 Valerion Therapeutics Pompe Disease Treatment Major Product Offerings
7.4.4 Valerion Therapeutics Pompe Disease Treatment Revenue in Global (2016-2021)
7.7.5 Valerion Therapeutics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Pompe Disease Treatment Market Opportunities & Trends in Global Market
Table 2. Pompe Disease Treatment Market Drivers in Global Market
Table 3. Pompe Disease Treatment Market Restraints in Global Market
Table 4. Key Players of Pompe Disease Treatment in Global Market
Table 5. Top Pompe Disease Treatment Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Pompe Disease Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Pompe Disease Treatment Revenue Share by Companies, 2016-2021
Table 8. Global Companies Pompe Disease Treatment Product Type
Table 9. List of Global Tier 1 Pompe Disease Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pompe Disease Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Pompe Disease Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Pompe Disease Treatment Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Pompe Disease Treatment Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Pompe Disease Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Pompe Disease Treatment Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Pompe Disease Treatment Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Pompe Disease Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Pompe Disease Treatment Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Pompe Disease Treatment Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Pompe Disease Treatment Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Pompe Disease Treatment Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Pompe Disease Treatment Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Pompe Disease Treatment Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Pompe Disease Treatment Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Pompe Disease Treatment Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Pompe Disease Treatment Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Pompe Disease Treatment Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Pompe Disease Treatment Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Pompe Disease Treatment Revenue, (US$, Mn), 2022-2027
Table 30. Amicus Therapeutics Corporate Summary
Table 31. Amicus Therapeutics Pompe Disease Treatment Product Offerings
Table 32. Amicus Therapeutics Pompe Disease Treatment Revenue (US$, Mn), (2016-2021)
Table 33. Audentes Therapeutics Corporate Summary
Table 34. Audentes Therapeutics Pompe Disease Treatment Product Offerings
Table 35. Audentes Therapeutics Pompe Disease Treatment Revenue (US$, Mn), (2016-2021)
Table 36. Sanofi Genzyme Corporate Summary
Table 37. Sanofi Genzyme Pompe Disease Treatment Product Offerings
Table 38. Sanofi Genzyme Pompe Disease Treatment Revenue (US$, Mn), (2016-2021)
Table 39. EpiVax Corporate Summary
Table 40. EpiVax Pompe Disease Treatment Product Offerings
Table 41. EpiVax Pompe Disease Treatment Revenue (US$, Mn), (2016-2021)
Table 42. Oxyrane Corporate Summary
Table 43. Oxyrane Pompe Disease Treatment Product Offerings
Table 44. Oxyrane Pompe Disease Treatment Revenue (US$, Mn), (2016-2021)
Table 45. Sangamo BioSciences Corporate Summary
Table 46. Sangamo BioSciences Pompe Disease Treatment Product Offerings
Table 47. Sangamo BioSciences Pompe Disease Treatment Revenue (US$, Mn), (2016-2021)
Table 48. Valerion Therapeutics Corporate Summary
Table 49. Valerion Therapeutics Pompe Disease Treatment Product Offerings
Table 50. Valerion Therapeutics Pompe Disease Treatment Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Pompe Disease Treatment Segment by Type
Figure 2. Pompe Disease Treatment Segment by Application
Figure 3. Global Pompe Disease Treatment Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Pompe Disease Treatment Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Pompe Disease Treatment Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pompe Disease Treatment Revenue in 2020
Figure 8. By Type - Global Pompe Disease Treatment Revenue Market Share, 2016-2027
Figure 9. By Application - Global Pompe Disease Treatment Revenue Market Share, 2016-2027
Figure 10. By Region - Global Pompe Disease Treatment Revenue Market Share, 2016-2027
Figure 11. By Country - North America Pompe Disease Treatment Revenue Market Share, 2016-2027
Figure 12. US Pompe Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Pompe Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Pompe Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Pompe Disease Treatment Revenue Market Share, 2016-2027
Figure 16. Germany Pompe Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 17. France Pompe Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Pompe Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Pompe Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Pompe Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Pompe Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Pompe Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Pompe Disease Treatment Revenue Market Share, 2016-2027
Figure 24. China Pompe Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Pompe Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Pompe Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Pompe Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 28. India Pompe Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Pompe Disease Treatment Revenue Market Share, 2016-2027
Figure 30. Brazil Pompe Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Pompe Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Pompe Disease Treatment Revenue Market Share, 2016-2027
Figure 33. Turkey Pompe Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Pompe Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Pompe Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Pompe Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 37. Amicus Therapeutics Pompe Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Audentes Therapeutics Pompe Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Sanofi Genzyme Pompe Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. EpiVax Pompe Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Oxyrane Pompe Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Sangamo BioSciences Pompe Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Valerion Therapeutics Pompe Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Amicus Therapeutics
Audentes Therapeutics
Sanofi Genzyme
EpiVax
Oxyrane
Sangamo BioSciences
Valerion Therapeutics